A more sensible ambition would be to establish a floor price mechanism in the negotiation process. Setting a floor that reflects the value of a drug to patients would reward innovators only when ...
Citi analyst Steven Zaccone maintained a Neutral rating on Floor & Decor Holdings, Inc. (NYSE:FND) with an unchanged price target of $111.00. Zaccone opened a positive catalyst watch trading call ...